Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Life Science Reit Plc ( (GB:LABS) ) is now available.
Life Science REIT plc has revised its investment advisory agreement with Ironstone Asset Management Limited, changing the fee calculation basis from net asset value to the lower of net asset value and average market capitalisation. This adjustment, effective from April 2025, is expected to save the company £1.0 million annually, enhancing earnings per share by 0.3 pence. The revisions also remove the requirement for Ironstone to acquire shares in relation to 15% of the advisory fee, potentially impacting the company’s financial dynamics and stakeholder interests.
More about Life Science Reit Plc
Life Science REIT plc is a specialist property business focused on the UK’s expanding life science sector. The company aims to become the preferred property provider for life science firms in the UK, with assets located in key research and development hubs in Oxford, Cambridge, and London’s Knowledge Quarter. The company addresses the demand-supply imbalance for laboratory space in these areas and focuses on capital growth and increasing income.
YTD Price Performance: 21.05%
Average Trading Volume: 926,634
Technical Sentiment Signal: Sell
Current Market Cap: £161M
Find detailed analytics on LABS stock on TipRanks’ Stock Analysis page.